Prothena Corp Public Ltd Co (PRTA): Revenue
$9.68M
Year ended 2025-12-31
$54.53M
Trailing 12 months to 2026-06-30
-43.6%
3-year compound annual growth
+62.6%
5-year compound annual growth
+19.7%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.68M | -92.8% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $135.16M | +47.9% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $91.37M | +69.5% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $53.91M | -73.1% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $200.58M | n/m | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $853.0K | +4.8% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $814.0K | -14.8% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $955.0K | -96.5% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $27.52M | n/m | 2020-03-03, From 2017-01-01 |
| 2016-12-31 | $1.05M | -34.3% | 2019-03-15, From 2016-01-01 |
| 2015-12-31 | $1.61M | -96.8% | 2018-02-26, From 2015-01-01 |
| 2014-12-31 | $50.85M | n/m | 2017-02-27, From 2014-01-01 |
| 2013-12-31 | $676.0K | -74.6% | 2016-02-25, From 2013-01-01 |
| 2012-12-31 | $2.66M | n/a | 2015-03-13, From 2012-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Prothena Corp Public Ltd Co (PRTA) | 2025-12-31 | $9.68M | -92.8% |
| Precigen, Inc. (PGEN) | 2025-12-31 | $9.68M | +146.7% |
| Janux Therapeutics, Inc. (JANX) | 2025-12-31 | $10.00M | -5.6% |
| Zenas BioPharma, Inc. (ZBIO) | 2025-12-31 | $10.00M | +100.0% |
| International Stem Cell Corp (ISCO) | 2025-12-31 | $9.10M | +0.2% |
| BioAge Labs, Inc. (BIOA) | 2025-12-31 | $8.99M | n/a |
| Crescent Biopharma, Inc. (CBIO) | 2025-12-31 | $10.84M | n/a |
| Roivant Sciences Ltd. (ROIV) | 2026-03-31 | $8.26M | -71.6% |
| Jaguar Health, Inc. (JAGX) | 2025-12-31 | $11.51M | -1.5% |
Compare PRTA, PGEN, JANX, ZBIO side by side · Screen every company in Pharmaceutical Preparations ↗